1 / 28

Welcome Alzheimer’s Disease Research Update: What’s New in 2014

Welcome Alzheimer’s Disease Research Update: What’s New in 2014. Please take this opportunity to complete the Pre-Test located on the pink form in your folders NYU Alzheimer’s Disease Center Silberstein Alzheimer’s Institute Center for Cognitive Neurology.

aaron
Download Presentation

Welcome Alzheimer’s Disease Research Update: What’s New in 2014

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. WelcomeAlzheimer’s Disease Research Update: What’s New in 2014 Please take this opportunity to complete the Pre-Test located on the pink form in your folders NYU Alzheimer’s Disease Center Silberstein Alzheimer’s Institute Center for Cognitive Neurology

  2. Body Fat and Muscle: Relationship to Cognitive and Physical Decline James E. Galvin, MD, MPH NYU Alzheimer’s Disease Center Supported by grants from the National Institute on Aging, Morris and Alma Schapiro Fund and Michael J Fox Foundation

  3. Acknowledgements • Galvin Lab • Magdalena Tolea, PhD • Chaim Tarshish, PhD • Arline Faustin, MD • Stephanie Chrisphonte, MD • Yael Zweig, MSN, ANP, GNP • Licet Valois, LMSW, MPS • Crystal Quinn, LMSW • Katty Saravia, CCMA • New York University • Stella Karantzoulis, PhD • Victoria Raveis, PhD • Marie Boltz, PhD • Ab Brody, PhD • Els Fieremans, PhD • Tim Shepard, MD, PhD • Jean Bear-Lehman, PhD • Washington University • John Morris, MD • Linda Larson-Prior, PhD • University of Kansas • David Johnson, PhD

  4. Definitions Physical Function Cognitive Function Healthy brain aging: little to no loss of memory or thinking abilities but tend to do things slower Mild Cognitive Impairment: transitional stage between healthy brain aging and dementia Dementia: progressive decline in memory and thinking that interferes with everyday function Alzheimer’s disease: most common cause of dementia • Physical Functionality: physical ability to independently carry out activities of daily living • Frailty: geriatric syndrome with high risk of declines in health and function • 5 dimensions: weight loss, exhaustion, weakness, slowness, and low activity • Muscle weakness: inability to exert force with one's skeletal muscles • Sarcopenia: degenerative loss of muscle mass, quality, and strength • Functional dependence: disability in one or more of seven basic activities of daily living (toileting, eating, dressing, etc.)

  5. What is the evidence? • Data support a relationship between physical function and cognition function • Difficult to determine the causal relationship • What comes first? • Cognitive evaluation may be difficult for many primary care physicians, who will be the first contact for many patients but physical assessments are already part of what they do • If physical impairment can be detected before noticeable cognitive impairment, performance-based assessments may help identify people at-risk for dementia

  6. Cognitive Physical Impairment Faster Progression Earlier Onset low low high high Rajan KB et al., JGMS 67:1419-1426, 2012

  7. Mild Physical Impairment Predicts Future AD HR: 1.06; 95% CI:1.01-1.12 Controlled for age, ApoE Wilkins CH, et al JAGS 2013

  8. Multicultural Community Dementia Screening • Supported by grant from the National Institute on Aging • Community-based assessment of older adults (target goal 500) • Demographics, financial resources, preferences • Cognitive-Behavioral Screening (memory, mood) • Medical Screening (blood pressure, diabetes, lung disease, obesity) • Physical assessment (balance, frailty, strength) • Anthropometric measurements • Social work follow-up • Subset have Gold Standard testing and biomarkers collected • MRI scans • PET scans • EEG • Blood • Spinal fluid • Rich dataset with over 500,000 individual data points

  9. Body Composition Bone Water Lean Muscle Fat Body Visceral

  10. Measurement Tools Body Composition - Impedance Dynamometer – Grip Strength Tape Measure – Girth

  11. Mini-PPT • Changes in the Mini PPT scores correlate with disability, loss of independence, the risk of falls, and mortality. • Cutoff scores of less than 12 imply impaired physical functioning • Sensitivity: 86% • Specificity: 90% • Assessment takes ~7 minutes • Range of Scores • >12 Unimpaired • 8-11 Mild • 5-7 Moderate • 0-4 Severe

  12. MoCA • 30 point, 10 minute cognitive screen to detect MCI and AD1 • Memory, constructions, attention, executive function, language and orientation1 • Score less than 26 suggests impairment2 • Utility in an office setting established1,3 • Also sensitive to PD-related dementia2 • Sensitivity ~90%, Specificity ~87%1 • http://www.mocatest.org 1. Nasreddine ZS et al, J Am Geriatr Soc. 2005;53:695-699. 2. Zadikoff et al, Mov Disord. 2008;23:297-299. 3. Smith et al, Can J Psych. 2007;52:329-332.

  13. AD8 • Detect change in individuals compared to previous level of function • No need for baseline assessment • Patients serve as their own control • Little bias by education, race, gender • Brief (< 2 min), Yes/No format • 2 or more “Yes” answers highly correlated with presence of dementia • AUC: 0.917 (95% CI: 0.88-0.95) • Sensitivity: 92% • Positive PV: 93%

  14. Biophysiological Markers of Health in a Multicultural Community Galvin and Tolea In preparation 2014

  15. Distribution Across Community Sample % Body Fat Visceral Fat

  16. Distribution Across Community Sample % Body Water Lean Muscle Mass

  17. Is Sarcopenia a Risk Factor? • Categories • No Sarcopenia: absence of both low muscle mass and grip strength • Pre-sarcopenia: presence of low muscle mass only • Sarcopenia: both low muscle mass and grip strength

  18. Sarcopenia and Impairment p<0.001 Tolea and Galvin, In Preparation 2014

  19. Staging Physical Impairment as Risk for Cognitive Impairment • Relationship between cognitive and physical functionality is well established at later stages of disability, however it is less clear whether association extends to the earliest stages of impairment • Measurements included: • upper extremity (UE) muscle strength (mean grip strength) • lower extremity (LE) function (Mini Physical Performance Test), • Cognition (Montreal Cognitive Assessment) • Participants were categorized: • no physical impairment • UE functional impairment • LE functional impairment • both UE and LE impairment

  20. Stage of Function and Cognition * *

  21. Relationship of BMI to Function MoCA r=.02 Mini-PPT r=.14

  22. Differences: Visceral and Body Fat Body Fat Visceral Fat MoCA r=.19 MoCA r=.03 Mini-PPT r=.13 Mini-PPT r=.36 Worse Cognitive Performance Worse Physical Performance

  23. Abdomen/Hip Ratio as Proxy Marker MoCA r=.23 Worse Outcomes Mini-PPT r=.07

  24. Falls RiskCognitive vs. Physical Status

  25. Initial Pass of Falls Risk Factor • Demographic Variables • Increasing age, female, living alone, self-reported memory problems, self-reported mood problems • Clinical/Anthropometric Variables • Body water, fat, visceral fat, bone density, muscle mass, pulse pressure • Cognitive Variables • List learning, visuoconstructive, trailmaking • Performance Variables • Grip strength, timed walk, flexion, progressive Romberg

  26. Summary • Relationship between cognitive and physical function is complex and bidirectional • Physical impairments are strong risk factors for future cognitive impairment • Once present, cognitive decline is stronger driver for further physical decline • Loss of muscle mass and strength (sarcopenia) may be one of the earliest detectable warning signs of impending cognitive decline • 3 to 6-fold increased risk • Strength testing (via dynamometer) is easy to do • Grip strength earlier and stronger predictor than just testing mobility • The association between cognitive and physical functionality follows a pattern from no impairment to loss of UE muscle strength to LE functional impairment • May explain up to 27% of variability in performance on cognitive tests • Falls are a significant consequence of both cognitive and physical decline • 1st fall increases risk of 2nd fall and may further drive cognitive and physical decline • Our initial work developed a profile of individuals at risk for falls

  27. Summary • Poorly controlled medical conditions greatly increase the risk of AD • May be multiple pathways to get to Alzheimer’s disease • May also be multiple pathways to prevent or treat • Interventions designed to prevent sarcopenia, increase lean muscle mass and improve strength may help reduce the burden of cognitive and physical impairments in community-dwelling older adults • Efforts to prevent cognitive decline and development of dementia may be more successful when directed to at at-risk individuals based on their physical functional profile • Detection of and interventions addressing physical impairments may offer novel approaches to reducing cognitive decline and falls • Prevention measures • Stay mentally alert, physically fit and eat a heart-healthy diet • AD is a disease of a lifetime; many ways to build a better brain as we age

  28. New York University Resources • Pearl I. Barlow Center for Memory Evaluation and Treatment • Specialty Faculty Practice • Multidisciplinary Approach • 212-263-3210 • www.nyulmc.org/barlow • Alzheimer Disease Center • Longitudinal Research Project • 212-263-8088 • www.adc.med.nyu.edu • Clinical Trials Center • Study New and Exciting Treatments for Dementia • 212-263-5708

More Related